Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial

Stephanie M. de Boer, Melanie Powell, Linda Mileshkin, +69

The Lancet Oncology

Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial

Stephanie M. de Boer, Melanie Powell, Linda Mileshkin, +67

The Lancet Oncology

The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology guidelines for the management of patients with cervical cancer

David Cibula, Richard Pötter, François Planchamp, +21

Radiotherapy and Oncology

Cervical Cancer ScreeningCervical Cancer ManagementCervical CancerCervical HealthGynecological Surgery +12

The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology Guidelines for the Management of Patients with Cervical Cancer

David Cibula, Richard Pötter, François Planchamp, +21

Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin

Cervical Cancer ScreeningCervical Cancer ManagementCervical CancerCervical HealthGynecological Surgery +12

International Brachytherapy Practice Patterns: A Survey of the Gynecologic Cancer Intergroup (GCIG)

Akila N. Viswanathan, Carien L. Creutzberg, Peter Craighead, +11

International Journal of Radiation Oncology*Biology*Physics

Radiation TherapyMedicineGynecologic Cancer IntergroupCancer ManagementBrachytherapy +5

SENTICOL III: an international validation study of sentinel node biopsy in early cervical cancer. A GINECO, ENGOT, GCIG and multicenter study

Fabrice Lécuru, Mary McCormack, Peter Hillemanns, +10

International Journal of Gynecological Cancer

A phase II study of weekly neoadjuvant chemotherapy followed by radical chemoradiation for locally advanced cervical cancer

Mary McCormack, Latha Kadalayil, Allan Hackshaw, +9

British Journal of Cancer

Randomized Phase II Trial of Ridaforolimus in Advanced Endometrial Carcinoma

Amit M. Oza, Sandro Pignata, Andrés Poveda, +8

Journal of Clinical Oncology

Cediranib combined with carboplatin and paclitaxel in patients with metastatic or recurrent cervical cancer (CIRCCa): a randomised, double-blind, placebo-controlled phase 2 trial

R.P. Symonds, Charlie Gourley, S.E. Davidson, +15

The Lancet Oncology

Induction chemotherapy followed by standard chemoradiotherapy versus standard chemoradiotherapy alone in patients with locally advanced cervical cancer (GCIG INTERLACE): an international, multicentre, randomised phase 3 trial

Mary McCormack, Gemma Eminowicz, Dolores Gallardo, +29

The Lancet

Advanced Cervical CancerCervical Cancer ManagementCervical CancerRadiation TherapyMedicine +8